Ex-drug exec Shkreli's U.S. fraud trial set for June 2017

NEW YORK, July 14 (Reuters) - A federal judge on Thursday

scheduled a trial for June 2017 in the U.S. government's

securities fraud case against former pharmaceutical executive

Martin Shkreli, who...

Read more